März 31, 2026
Regulatory

Why Medtech Is No Longer Competing on Equal Terms

Why access to real-world data is becoming a defining factor in medtech — and how companies can position themselves.

Part 4 of the series “The New Rules of Medtech” by Sandra Heeg, Editor-in-Chief, MedTech Media Europe.

Not all medtech companies are operating under the same conditions anymore.

 

For a long time, competition was defined by products:

better performance, improved usability, incremental innovation.

 

That logic still applies — but it no longer explains the full picture.

 

A less visible shift is taking place in parallel:

 

The ability to generate and use data is becoming a key factor in how products evolve — and how companies compete.

 

Much of the current discussion focuses on how companies can use data more effectively.

Less attention is paid to how access to that data is distributed across the industry.

 

From product performance to data-enabled improvement

 

Traditionally, product performance was established through:

- controlled clinical studies

- engineering expertise

- regulatory approval

 

Once on the market, improvements were typically:

- incremental

- periodic

- largely internal

 

Today, a different dynamic is emerging:

 

Products are increasingly improved based on continuous feedback from real-world use.

 

Why data access differs across the industry

 

Access to relevant data is shaped by structural factors such as installed base, integration into clinical environments, software capabilities and partnerships.

 

A shift in how competitive advantage is built

 

Traditional advantages can be replicated.

Data-enabled advantages build over time and depend on access and integration.

 

Unlike traditional product features, these advantages are not easily replicated through engineering alone.

 

Data is becoming an additional layer of competitive differentiation — not a replacement for established factors.

 

A changing role for suppliers and partners

 

Manufacturers typically have direct access to relevant data.

Suppliers often interact with it indirectly.

 

Access is therefore not absent, but mediated and context-dependent.

 

For suppliers, this increases the importance of integration, interoperability and contribution to data processes.

 

What this means for manufacturers

 

Data access becomes strategic and shifts discussions toward positioning within data-generating environments.

 

Learning speed becomes a differentiator.

 

Conclusion

 

The question is no longer only who is best at using data — but who is structurally positioned to generate and access it.

 

Author: Sandra Heeg

© 2026 Sandra Heeg. All rights reserved. Copyright retained by the author. Publication on medtechmediaeurope.com is permitted by the author and may be withdrawn at any time.